You've heard the phrase "a force of nature," but we'd have to say that the University of Pittsburgh is clearly a force of science based on several recent news items: the University ranks in the Top 3 among public institutions of higher learning in the US (according to the NSF); they're in the Top 5 in federally financed research and development expenditures; and they've just had 3 of their faculty scientists elected to the prestigious National Academy of Sciences. Chancellor Mark Nordenberg says of the first honor:
There's been a lot of news coming out of Chicago this week from the annual meeting of the American Association for Cancer Research (AACR). Two announcements concerning prostate cancer research are especially worth broadcasting. An Ann Arbor pathologist, Arul M. Chinnaiyan, of the University of Michigan Comprehensive Cancer Center, will be leading a "dream team" of specialists from 5 of the top cancer research institutes in the world in a $10M, 3-year research project titled “Precision Therapy for Advanced Prostate Cancer.” The funding comes from AACR partner, Stand Up To Cancer (SU2C), and the Prostate Cancer Foundation (PCF). Heading up the team with Dr. Chinnaiyan is Dr. Charles L. Sawyers of Memorial Sloan-Kettering Cancer Center in New York.
Tags: University of Michigan, Midwest, Bioresearch, cancer research, nanotechnology, genome research, genomic medicine, 2012, Ann Arbor, BioResearch Product Faire Event, Funding, Research Funding, Conference, MI, science event, scientific conference, science current event, scientific events, UMich, Cancer Center, science research funding